Proteomics as a tool for assessment of therapeutics in transfusion medicine: evaluation of prothrombin complex concentrates.
BACKGROUND
Proteomic technologies are evolving tools to analyze complex protein patterns that to date have been rarely applied to transfusion medicine. The analysis of prothrombin complex concentrates (PCCs) was used as a model to evaluate to what extent these technologies can detect differences in blood-derived therapeutics beyond that of standard quality control.


METHODS
Three PCCs (two batches each) were individually analyzed for differences in protein content by functional assays, two-dimensional gel electrophoresis, and mass spectrometry. The results were compared to a pool of 72 normal plasma samples.


RESULTS
A highly complex protein pattern was found that varied considerably among the three PCCs: 192 spots comprising 40 different proteins were identified. Factor (F) IX activities of the three PCCs were comparable, but their F IX protein contents differed considerably. Many proteins were present in multiple spots (e.g. FII, FX, protein C, vitronectin), indicating a high degree of posttranslational modifications. In comparison with untreated pooled plasma, PCCs displayed several low-molecular-weight variants of proteins that likely constitute potential degradation products.


CONCLUSIONS
Proteomic technologies allow the identification of potentially modified proteins in clotting factor concentrates, indicating that they could become a useful tool for transfusion medicine to assess the impact of processing on the integrity of blood-derived therapeutics.
Brigulla
Matthias
M
Institute for Immunology and Transfusion Medicine, the Laboratory for Functional Genomics, Ernst-Moritz-Arndt University, Greifswald, Germany.
Thiele
Thomas
T
Scharf
Christian
C
Breitner-Ruddock
Susanne
S
Venz
Simone
S
Völker
Uwe
U
Greinacher
Andreas
A
D001774:Blood Chemical Analysis / Q000379:methods; D001779:Blood Coagulation Factors / Q000032:analysis* / Q000737:chemistry; D016913:Blood Component Transfusion; D005260:Female; D006801:Humans; D008297:Male; D010949:Plasma / Q000737:chemistry*; D040901:Proteomics / Q000379:methods; D012680:Sensitivity and Specificity
D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates